ArcScan, Inc.

ArcScan, Inc.

Advancing ophthalmic ultrasound imaging with images that capture the entire anterior segment.

Founded 2007

Golden, United States 15 employees Series B Total: $14.82M Health Care, Medical Devices

ArcScan, Inc. is a health care startup founded in 2007 and headquartered in the United States. The company's slogan, "The New Standard in Ophthalmic Ultrasound: Improve Lives. Worry Less." encapsulates its mission to revolutionize ophthalmic ultrasound technology. The $11.15M Series B investment received on 21st July 2021, led by Haohai Biological Technology, indicates a significant validation of ArcScan's innovative approach. ArcScan's flagship product, the ArcScan Insight© 100, sets itself apart with its easy-to-use ultrasound device that offers unparalleled repeatability and accuracy in imaging and measurements of the eye anatomy, particularly behind the iris. The clinical benefits of the device are extensive, encompassing improved surgical outcomes, better treatment planning, and early detection of vision impairing conditions such as keratoconus. This innovative approach not only addresses medical needs but also emphasizes patient comfort and ease through its non-invasive ultrasound technology. Overall, ArcScan, Inc. embodies the potential to make a significant impact in the ophthalmic field, evidenced by its recent successful funding round and the promising clinical benefits offered by its cutting-edge technology. As a venture capital analyst, the company's demonstrated ability to attract significant investments and its pioneering efforts in the health care industry make it a compelling prospect for consideration.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$11.15M	1	Haohai Biological Technology	21 Jul 2021
Series A	$3.67M	-		19 Feb 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$11.15M

Haohai Biological Technology

21 Jul 2021

Series A

$3.67M

19 Feb 2015

FAQ About ArcScan, Inc.

Advancing ophthalmic ultrasound imaging with images that capture the entire anterior segment.

ArcScan, Inc. was founded in 2007.

ArcScan, Inc. is headquartered in Golden, United States.

ArcScan, Inc. operates in Health Care and Medical Devices. Its work centres on Ophthalmology, Ultrasound technology, Refractive surgery and ICL Sizing.

ArcScan, Inc. has approximately 15 employees.

ArcScan, Inc. has completed 2 funding rounds, raising a total of $14.82M. The latest funding stage is Series B.

Top alternatives and competitors to ArcScan, Inc. include Northwest Eye Surgeons, Avedro, KERANOVA S.A., Heidelberg Engineering, EYETECHCARE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ArcScan, Inc. and Northwest Eye Surgeons are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About ArcScan, Inc.

Funding Rounds & Investors (2)

ArcScan, Inc. Alternatives & Competitors

FAQ About ArcScan, Inc.